Qasim Iftikhar Ahmad - 17 Jul 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role: Chief Medical Officer
Signature: /s/ Brian Burkavage, Attorney-in-Fact for Qasim Ahmad
Issuer symbol: IOBT
Transactions as of: 17 Jul 2023
Net transactions value: $0
Form type: 4
Filing time: 19 Jul 2023, 16:20:18 UTC
Previous filing: 19 Jul 2023
Next filing: 18 Mar 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IOBT	Stock Option (Right to Buy)	Award	$0	+288,153		$0.000000	288,153	17 Jul 2023	Common Stock	288,153	$1.86	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-fourth of these options vest on July 17, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.

Content

One-fourth of these options vest on July 17, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.